Organization: Health Canada
Year: 2023
Month: November
Request Number: A-2023-000631
Request Summary: Adverse Drug Reactions (ADRs) for MEZAVANT. Report numbers: 001042210, E2B_06389094. ADRs for MESALAZINE. Report numbers: E2B_06363129, E2B_06343271, E2B_06349976. ADR for ANTIHEMOPHILIC FACTOR. Report number: E2B_06361268. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_06405702, E2B_06381733, E2B_06362541, E2B_06333449.
Disposition: Disclosed in part
Number of pages: 89